Systemic lupus erythematosus and Sjögren's syndrome induced in a case by interferon-alpha used for the treatment of hepatitis C.

Onishi, S; Nagashima, T; Kimura, H; Matsuyama, Y; Yoshio, T; Minota, S

Onishi, S; Nagashima, T; Kimura, H; Matsuyama, Y; Yoshio, T; Minota, S.

Affiliation

Onishi S; Division of Rheumatology and Clinical Immunology, Jichi Medical University, Japan. osachiko@csc.jp

Lupus ; 19(6): 753-5, 2010 May.

Article in En | MEDLINE | ID: mdl-20064909

Subject(s)

Antiviral Agents/adverse effects; Antiviral Agents/therapeutic use; Hepatitis C/drug therapy; Interferon-alpha/adverse effects; Interferon-alpha/therapeutic use; Lupus Erythematosus, Systemic/etiology; Sjogren's Syndrome/etiology; Antibodies, Antinuclear/immunology; Antiviral Agents/immunology; Female; Glucocorticoids/therapeutic use; Humans; Interferon-alpha/immunology; Lupus Erythematosus, Systemic/drug therapy; Lupus Erythematosus, Systemic/immunology; Middle Aged; Ribavirin/therapeutic use; Sjogren's Syndrome/drug therapy; Sjogren's Syndrome/immunology; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Sjogren's Syndrome / Interferon-alpha / Hepatitis C / Lupus Erythematosus, Systemic Limits: Female / Humans / Middle aged Language: En Journal: Lupus Journal subject: REUMATOLOGIA Year: 2010 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google